Alcon, Inc., an eye care company, researches, develops, manufactures, distributes and sells eye care products for eye care professionals and their patients around the world. The company is headquartered in Geneva, Switzerland.
| Revenue (TTM) | $10.63B |
| Gross Profit (TTM) | $5.93B |
| EBITDA | $2.27B |
| Operating Margin | 10.80% |
| Return on Equity | 3.71% |
| Return on Assets | 2.47% |
| Revenue/Share (TTM) | $21.65 |
| Book Value | $45.38 |
| Price-to-Book | 1.49 |
| Price-to-Sales (TTM) | 3.11 |
| EV/Revenue | 3.444 |
| EV/EBITDA | 14.42 |
| Quarterly Earnings Growth (YoY) | -44.60% |
| Quarterly Revenue Growth (YoY) | 9.40% |
| Shares Outstanding | $487.70M |
| Float | $486.15M |
| % Insiders | 0.17% |
| % Institutions | 66.14% |
Volatility is currently contracting